Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)
Sep 16
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedSep 18, 2025
DataAggregated Company Financials
Companies18
- 7D-2.3%
- 3M-8.3%
- 1Y-13.1%
- YTD-11.5%
Over the last 7 days, the Healthcare industry has dropped 2.9%, driven by a pullback from Recordati Industria Chimica e Farmaceutica of 2.6%. In contrast, GVS has gained 6.9%. The industry has fallen 14% in the last year. As for the next few years, earnings are expected to grow by 14% per annum.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 18 Sep 2025 | €22.5b | €8.7b | €894.6m | 19.9x | 25.2x | 2.6x |
| Sat, 16 Aug 2025 | €22.5b | €8.7b | €902.9m | 19.4x | 24.9x | 2.6x |
| Mon, 14 Jul 2025 | €24.5b | €8.6b | €941.3m | 20.1x | 26.1x | 2.8x |
| Wed, 11 Jun 2025 | €24.2b | €25.2b | €985.5m | 19.7x | 24.5x | 1x |
| Fri, 09 May 2025 | €23.1b | €20.1b | €910.9m | 18.2x | 25.3x | 1.1x |
| Sun, 06 Apr 2025 | €22.0b | €20.1b | €907.3m | 16.7x | 24.3x | 1.1x |
| Tue, 04 Mar 2025 | €24.6b | €20.0b | €821.4m | 23.3x | 30x | 1.2x |
| Thu, 30 Jan 2025 | €25.9b | €7.9b | €829.1m | 23.4x | 31.3x | 3.3x |
| Sat, 28 Dec 2024 | €24.2b | €18.7b | €1.4b | 20.7x | 17x | 1.3x |
| Mon, 25 Nov 2024 | €24.7b | €19.0b | €1.4b | 19x | 17.3x | 1.3x |
| Wed, 23 Oct 2024 | €25.6b | €18.9b | €1.4b | 17.7x | 18.6x | 1.4x |
| Fri, 20 Sep 2024 | €25.0b | €18.9b | €1.4b | 16.6x | 17.9x | 1.3x |
| Sun, 18 Aug 2024 | €25.3b | €18.9b | €1.4b | 14.5x | 18.3x | 1.3x |
| Tue, 16 Jul 2024 | €25.9b | €18.8b | €1.4b | 17.2x | 18.7x | 1.4x |
| Thu, 13 Jun 2024 | €26.0b | €18.8b | €1.4b | 16.8x | 18.8x | 1.4x |
| Sat, 11 May 2024 | €26.7b | €18.8b | €1.4b | 19.1x | 19.3x | 1.4x |
| Mon, 08 Apr 2024 | €24.6b | €18.7b | €1.4b | 19.1x | 17.9x | 1.3x |
| Wed, 06 Mar 2024 | €25.2b | €18.6b | €1.4b | 19x | 18x | 1.4x |
| Fri, 02 Feb 2024 | €24.5b | €18.6b | €1.4b | 20.2x | 17.6x | 1.3x |
| Sun, 31 Dec 2023 | €24.9b | €18.6b | €1.4b | 18.9x | 17.9x | 1.3x |
| Tue, 28 Nov 2023 | €23.0b | €18.6b | €1.4b | 18.4x | 16.5x | 1.2x |
| Thu, 26 Oct 2023 | €22.2b | €18.6b | €1.4b | 16.2x | 15.3x | 1.2x |
| Sat, 23 Sep 2023 | €22.9b | €17.3b | €1.1b | 16.3x | 20.2x | 1.3x |
| Mon, 21 Aug 2023 | €23.1b | €17.3b | €1.1b | 15.3x | 20.3x | 1.3x |
| Wed, 19 Jul 2023 | €23.6b | €7.7b | €822.5m | 15.9x | 28.7x | 3.1x |
| Fri, 16 Jun 2023 | €25.0b | €7.7b | €822.5m | 19.5x | 30.4x | 3.2x |
| Sun, 14 May 2023 | €25.4b | €7.7b | €852.8m | 21.9x | 29.8x | 3.3x |
| Tue, 11 Apr 2023 | €23.4b | €7.5b | €824.2m | 21.6x | 28.4x | 3.1x |
| Thu, 09 Mar 2023 | €23.9b | €7.5b | €867.3m | 24.4x | 27.6x | 3.2x |
| Sat, 04 Feb 2023 | €24.0b | €7.4b | €886.1m | 23.8x | 27.1x | 3.2x |
| Mon, 02 Jan 2023 | €23.9b | €7.4b | €886.1m | 23x | 26.9x | 3.2x |
| Wed, 30 Nov 2022 | €23.9b | €7.4b | €886.1m | 22.2x | 27x | 3.2x |
| Fri, 28 Oct 2022 | €22.5b | €7.3b | €908.8m | 19.9x | 24.7x | 3.1x |
| Sun, 25 Sep 2022 | €21.7b | €7.2b | €899.3m | 20.4x | 24.1x | 3x |
Price to Earnings Ratio
24.1x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 23.0x.
- The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 6.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 0.0031% | |
| Healthcare | -2.32% | |
| Healthtech | 4.31% | |
| Life Sciences | -0.22% | |
| Medical Equipment | -1.82% | |
| Pharma | -2.59% | |
| Biotech | -2.65% | |
| Healthcare Services | -3.26% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.0x.
- Analysts are expecting annual earnings growth of 24.7%, which is lower than the prior year's growth of 1,454.1% per year.
- Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 22.3x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- In contrast, the Biotech industry is expected to see its earnings decline by 35% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GVS GVS | €4.78 | 6.9% +€58.5m | -25.9% | PE58.6x | |
| GPI GPI | €17.92 | 4.3% +€21.4m | 39.8% | PE34x | |
| GHC Garofalo Health Care | €4.98 | 0.9% +€3.3m | -6.7% | PE19.8x | |
| IMD I.M.D. International Medical Devices | €1.58 | 8.2% +€2.1m | 15.3% | PE12.3x | |
| ARBS Arterra Bioscience | €2.78 | 10.3% +€1.7m | 39.7% | PE13.8x |
